Avivagen (TSXV:VIV) Capital Expenditure : C$0.00 Mil (TTM As of Jul. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Avivagen Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Avivagen's cash flow for capital expenditures for the three months ended in Jul. 2023 was C$0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jul. 2023 was C$0.00 Mil.

Avivagen Capital Expenditure Historical Data

The historical data trend for Avivagen's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avivagen Capital Expenditure Chart

Avivagen Annual Data

Trend

Oct13

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Capital Expenditure

Get a 7-Day Free Trial

-0.07

-0.11

-0.04

-0.01

Avivagen Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Capital Expenditure	Get a 7-Day Free Trial															-	-	-	-	-

Avivagen Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Avivagen (TSXV:VIV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avivagen Inc (TSXV:VIV) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

VIVXF:USA

Address

100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6

Website

https://www.avivagen.com

Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.